Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neck Disease, Head and Neck Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07823439
What this trial is testing

Pattern and Surgical Outcome of Papillary Thyroid Cancer at Sohag University Hospitals

Who this might be right for
Papillary Thyroid CarcinomaThyroid Cancer
Sohag University 30
Not applicableWithdrawnNCT03110939
What this trial is testing

Thoracic Surgery Combined With Intrathoracic Hyperthermic Perfusion for Advanced Lung Cancer / Esophageal Cancer

Who this might be right for
Esophageal CancerLung CancerHyperthermic Perfusion
Henan Cancer Hospital
Testing effectiveness (Phase 2)Study completedNCT04428151
What this trial is testing

Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma That Progressed After Platinum Therapy and Immunotherapy (MK-7902-009/E7080-G000-228/LEAP-009)

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Merck Sharp & Dohme LLC 408
Not applicableUnknownNCT06342739
What this trial is testing

Verbal Synchrony, Satisfaction and Decision-making in Face-to-face Consultations

Who this might be right for
Thyroid Nodule
European Institute of Oncology 60
Early research (Phase 1)Study completedNCT03739931
What this trial is testing

Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies

Who this might be right for
Dose Escalation: Relapsed/Refractory Solid Tumor Malignancies or LymphomaDose Expansion: Triple Negative Breast Cancer, HNSCC, Non-Hodgkins, Urothelial Cancer, Immune Checkpoint Refractory Melanoma, and NSCLC Lymphoma
ModernaTX, Inc. 134
Not applicableLooking for participantsNCT07410637
What this trial is testing

Impact of Thyroid Hormones on Human Glucose and Energy Metabolism

Who this might be right for
Graves DiseaseThyroid Cancer
University of Ulm 60
Early research (Phase 1)Study completedNCT00437372
What this trial is testing

Phase IB Study Using Sunitinib Plus Radiation Therapy for Cancer Patients

Who this might be right for
CancerHead and Neck CancerPelvic Cancer+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 39
Not applicableStudy completedNCT07102329
What this trial is testing

BURDEN OF ESOPHAGEAL CANCER IN EOSINOPHILIC ESOPHAGITIS (ESCAPE STUDY)

Who this might be right for
Eosinophilic Esophagitis (EoE)
IRCCS San Raffaele 100,000
Not applicableUnknownNCT02017002
What this trial is testing

Comparison of Ivor Lewis and Tri-incision Approaches for Patients With Esophageal Cancer

Who this might be right for
Surgical ProceduresMinimally InvasiveOperative+3 more
National Taiwan University Hospital 100
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Testing effectiveness (Phase 2)Study completedNCT00305734
What this trial is testing

Bortezomib and Gemcitabine in Treating Patients With Recurrent or Metastatic Nasopharyngeal Cancer

Who this might be right for
Recurrent Nasopharyngeal CancerStage IV Nasopharyngeal Cancer
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT00580320
What this trial is testing

Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma

Who this might be right for
MelanomaSoft Tissue SarcomaParathyroid Carcinoma+2 more
Virginia Commonwealth University 17
Not applicableStudy completedNCT03049280
What this trial is testing

Prospective, Multicenter da Vinci® SP™ Surgical System TORS Study

Who this might be right for
Oropharyngeal Cancer
Intuitive Surgical 33
Not applicableStudy completedNCT02724488
What this trial is testing

Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies

Who this might be right for
Head and Neck CancerMelanoma
University Health Network, Toronto 14
Testing effectiveness (Phase 2)Ended earlyNCT03122548
What this trial is testing

Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers

Who this might be right for
Gastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaEsophageal Adenocarcinoma
Aduro Biotech, Inc. 5
Not applicableEnrolling By InvitationNCT06990178
What this trial is testing

Adaptive Neoadjuvant Therapy for Esophageal Cancer

Who this might be right for
Esophageal CarcinomaNeoadjuvant Therapy
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center 43
Testing effectiveness (Phase 2)UnknownNCT05860335
What this trial is testing

Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer

Who this might be right for
Hypopharyngeal Cancer
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)UnknownNCT01697891
What this trial is testing

A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers

Who this might be right for
Head and Neck CancerDysphagia
McMaster University 35
Not applicableStudy completedNCT03335813
What this trial is testing

Endoesophageal Brachytherapy for Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
Case Comprehensive Cancer Center 7
Early research (Phase 1)Study completedNCT00622674
What this trial is testing

Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+5 more
Masonic Cancer Center, University of Minnesota 37
Next Page